| Year |
Citation |
Score |
| 2021 |
Boonyalai N, Thamnurak C, Sai-Ngam P, Ta-Aksorn W, Arsanok M, Uthaimongkol N, Sundrakes S, Chattrakarn S, Chaisatit C, Praditpol C, Fagnark W, Kirativanich K, Chaorattanakawee S, Vanachayangkul P, Lertsethtakarn P, ... ... Lanteri C, et al. Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand. Scientific Reports. 11: 13419. PMID 34183715 DOI: 10.1038/s41598-021-92735-6 |
0.303 |
|
| 2019 |
Balasubramanian S, Rahman RS, Lon C, Parobek C, Ubalee R, Hathaway N, Kuntawunginn W, My M, Vy D, Saxe J, Lanteri C, Lin FC, Spring M, Meshnick SR, Juliano JJ, et al. Efficient Transmission of Mixed Plasmodium falciparum/vivax Infections From Humans to Mosquitoes. The Journal of Infectious Diseases. PMID 31549156 DOI: 10.1093/Infdis/Jiz388 |
0.316 |
|
| 2017 |
Chaorattanakawee S, Lon C, Chann S, Thay KH, Kong N, You Y, Sundrakes S, Thamnurak C, Chattrakarn S, Praditpol C, Yingyuen K, Wojnarski M, Huy R, Spring MD, Walsh DS, ... ... Lanteri CA, et al. Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia. Malaria Journal. 16: 392. PMID 28964258 DOI: 10.1186/S12936-017-2034-2 |
0.455 |
|
| 2017 |
Agrawal S, Moser KA, Morton L, Cummings MP, Parihar A, Dwivedi A, Shetty AC, Drabek EF, Jacob CG, Henrich PP, Parobek CM, Jongsakul K, Huy R, Spring MD, Lanteri CA, et al. Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity. The Journal of Infectious Diseases. 216: 468-476. PMID 28931241 DOI: 10.1093/Infdis/Jix334 |
0.361 |
|
| 2017 |
Parobek CM, Parr JB, Brazeau NF, Lon C, Chaorattanakawee S, Gosi P, Barnett EJ, Norris LD, Meshnick SR, Spring MD, Lanteri CA, Bailey JA, Saunders DL, Lin JT, Juliano JJ. Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia. Genome Biology and Evolution. 9: 1673-1686. PMID 28854635 DOI: 10.1093/Gbe/Evx126 |
0.42 |
|
| 2017 |
Lin JT, Lon C, Spring MD, Sok S, Chann S, Ittiverakul M, Kuntawunginn W, My M, Thay K, Rahman R, Balasubramanian S, Char M, Lanteri CA, Gosi P, Ubalee R, et al. Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial. Plos One. 12: e0168702. PMID 28591198 DOI: 10.1371/Journal.Pone.0168702 |
0.352 |
|
| 2017 |
Vanachayangkul P, Lon C, Spring M, Sok S, Ta-Aksorn W, Kodchakorn C, Pann ST, Chann S, Ittiverakul M, Sriwichai S, Buathong N, Kuntawunginn W, So M, Youdaline T, Milner E, ... ... Lanteri C, et al. Piperaquine population pharmacokinetics and cardiac safety in Cambodia. Antimicrobial Agents and Chemotherapy. PMID 28193647 DOI: 10.1128/Aac.02000-16 |
0.302 |
|
| 2016 |
Parobek CM, Lin JT, Saunders DL, Barnett EJ, Lon C, Lanteri CA, Balasubramanian S, Brazeau N, DeConti DK, Garba DL, Meshnick SR, Spring MD, Chuor CM, Bailey JA, Juliano JJ. Selective sweep suggests transcriptional regulation may underlie Plasmodium vivax resilience to malaria control measures in Cambodia. Proceedings of the National Academy of Sciences of the United States of America. PMID 27911780 DOI: 10.1073/Pnas.1608828113 |
0.347 |
|
| 2016 |
Chaorattanakawee S, Lon C, Jongsakul K, Gawee J, Sok S, Sundrakes S, Kong N, Thamnurak C, Chann S, Chattrakarn S, Praditpol C, Buathong N, Uthaimongkol N, Smith P, Sirisopana N, ... ... Lanteri C, et al. Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand. Malaria Journal. 15: 519. PMID 27769299 DOI: 10.1186/S12936-016-1569-Y |
0.38 |
|
| 2015 |
Saunders DL, Chaorattanakawee S, Gosi P, Lanteri C, Sok S, Kuntawunginn W, Ittiverakul M, Chann S, Gregory C, Chuor CM, Prom S, Spring MD, Lon C. Atovaquone-proguanil remains a potential stop-gap therapy in areas of multidrug resistant P. falciparum on the Thai-Cambodian border. Antimicrobial Agents and Chemotherapy. PMID 26711753 DOI: 10.1128/Aac.02302-15 |
0.409 |
|
| 2015 |
Chaorattanakawee S, Lanteri CA, Sundrakes S, Yingyuen K, Gosi P, Chanarat N, Wongarunkochakorn S, Buathong N, Chann S, Kuntawunginn W, Arsanok M, Lin JT, Juliano JJ, Tyner SD, Char M, et al. Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia. Malaria Journal. 14: 486. PMID 26626127 DOI: 10.1186/S12936-015-1021-8 |
0.382 |
|
| 2015 |
Chaorattanakawee S, Saunders DL, Sea D, Chanarat N, Yingyuen K, Sundrakes S, Saingam P, Buathong N, Sriwichai S, Chann S, Se Y, Yom Y, Heng TK, Kong N, Kuntawunginn W, ... ... Lanteri CA, et al. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance. Antimicrobial Agents and Chemotherapy. 59: 4631-43. PMID 26014942 DOI: 10.1128/Aac.00366-15 |
0.457 |
|
| 2015 |
Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, Se Y, Chann S, Ittiverakul M, Sia-Ngam P, Kuntawunginn W, Arsanok M, Buathong N, Chaorattanakawee S, Gosi P, ... ... Lanteri CA, et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. The Lancet. Infectious Diseases. 15: 683-91. PMID 25877962 DOI: 10.1016/S1473-3099(15)70049-6 |
0.431 |
|
| 2015 |
Lin JT, Hathaway NJ, Saunders DL, Lon C, Balasubramanian S, Kharabora O, Gosi P, Sriwichai S, Kartchner L, Chuor CM, Satharath P, Lanteri C, Bailey JA, Juliano JJ. Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse. The Journal of Infectious Diseases. PMID 25748326 DOI: 10.1093/Infdis/Jiv142 |
0.329 |
|
| 2015 |
Rutvisuttinunt W, Schaecher KE, Noedl H, Lon CT, Tyner S, Lanteri CA, Jongsakul K, Bethell D, Smith BL, Saunders DL, Fukuda MM. Sequence analysis of Plasmodium falciparum SERCAtype pfATPase6 in field isolates collected along Thai-Cambodian border Asian Biomedicine. 9: 343-351. DOI: 10.5372/1905-7415.0903.403 |
0.334 |
|
| 2014 |
Saunders D, Vanachayangkul P, Imerbsin R, Khemawoot P, Siripokasupkul R, Tekwani BL, Sampath A, Nanayakkara NP, Ohrt C, Lanteri C, Gettyacamin M, Teja-Isavadharm P, Walker L. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta). Antimicrobial Agents and Chemotherapy. 58: 7283-91. PMID 25267666 DOI: 10.1128/Aac.02576-13 |
0.312 |
|
| 2014 |
Manning J, Vanachayangkul P, Lon C, Spring M, So M, Sea D, Se Y, Somethy S, Phann ST, Chann S, Sriwichai S, Buathong N, Kuntawunginn W, Mitprasat M, Siripokasupkul R, ... ... Lanteri C, et al. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval. Antimicrobial Agents and Chemotherapy. 58: 6056-67. PMID 25092702 DOI: 10.1128/Aac.02667-14 |
0.32 |
|
| 2014 |
Lanteri CA, Chaorattanakawee S, Lon C, Saunders DL, Rutvisuttinunt W, Yingyuen K, Bathurst I, Ding XC, Tyner SD. Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia. Antimicrobial Agents and Chemotherapy. 58: 5831-40. PMID 25049252 DOI: 10.1128/Aac.02462-14 |
0.441 |
|
| 2014 |
Lon C, Manning JE, Vanachayangkul P, So M, Sea D, Se Y, Gosi P, Lanteri C, Chaorattanakawee S, Sriwichai S, Chann S, Kuntawunginn W, Buathong N, Nou S, Walsh DS, et al. Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial. Plos One. 9: e93138. PMID 24667662 DOI: 10.1371/Journal.Pone.0093138 |
0.355 |
|
| 2014 |
Givens MB, Lin JT, Lon C, Gosi P, Char MC, Lanteri CA, Saunders DL, Juliano JJ. Development of a capillary electrophoresis-based heteroduplex tracking assay to measure in-host genetic diversity of initial and recurrent Plasmodium vivax infections in Cambodia. Journal of Clinical Microbiology. 52: 298-301. PMID 24131693 DOI: 10.1128/Jcm.02274-13 |
0.324 |
|
| 2013 |
Gosi P, Lanteri CA, Tyner SD, Se Y, Lon C, Spring M, Char M, Sea D, Sriwichai S, Surasri S, Wongarunkochakorn S, Pidtana K, Walsh DS, Fukuda MM, Manning J, et al. Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia. Malaria Journal. 12: 403. PMID 24206588 DOI: 10.1186/1475-2875-12-403 |
0.376 |
|
| 2013 |
Chaorattanakawee S, Tyner SD, Lon C, Yingyuen K, Ruttvisutinunt W, Sundrakes S, Sai-gnam P, Johnson JD, Walsh DS, Saunders DL, Lanteri CA. Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia. Malaria Journal. 12: 239. PMID 23849006 DOI: 10.1186/1475-2875-12-239 |
0.383 |
|
| 2011 |
Opsenica I, Burnett JC, Gussio R, Opsenica D, Todorović N, Lanteri CA, Sciotti RJ, Gettayacamin M, Basilico N, Taramelli D, Nuss JE, Wanner L, Panchal RG, Solaja BA, Bavari S. A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus. Journal of Medicinal Chemistry. 54: 1157-69. PMID 21265542 DOI: 10.1021/Jm100938U |
0.389 |
|
| 2011 |
Hughes LM, Lanteri CA, O'Neil MT, Johnson JD, Gribble GW, Trumpower BL. Design of anti-parasitic and anti-fungal hydroxy-naphthoquinones that are less susceptible to drug resistance. Molecular and Biochemical Parasitology. 177: 12-9. PMID 21251932 DOI: 10.1016/J.Molbiopara.2011.01.002 |
0.475 |
|
| 2010 |
Milner E, McCalmont W, Bhonsle J, Caridha D, Cobar J, Gardner S, Gerena L, Goodine D, Lanteri C, Melendez V, Roncal N, Sousa J, Wipf P, Dow GS. Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols. Malaria Journal. 9: 51. PMID 20149249 DOI: 10.1186/1475-2875-9-51 |
0.313 |
|
| 2010 |
Milner E, McCalmont W, Bhonsle J, Caridha D, Carroll D, Gardner S, Gerena L, Gettayacamin M, Lanteri C, Luong T, Melendez V, Moon J, Roncal N, Sousa J, Tungtaeng A, et al. Structure-activity relationships amongst 4-position quinoline methanol antimalarials that inhibit the growth of drug sensitive and resistant strains of Plasmodium falciparum. Bioorganic & Medicinal Chemistry Letters. 20: 1347-51. PMID 20097070 DOI: 10.1016/J.Bmcl.2010.01.001 |
0.405 |
|
| 2008 |
Opsenica I, Opsenica D, Lanteri CA, Anova L, Milhous WK, Smith KS, Solaja BA. New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton. Journal of Medicinal Chemistry. 51: 6216-9. PMID 18774792 DOI: 10.1021/Jm8006905 |
0.306 |
|
| 2008 |
Lanteri CA, Tidwell RR, Meshnick SR. The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei. Antimicrobial Agents and Chemotherapy. 52: 875-82. PMID 18086841 DOI: 10.1128/Aac.00642-07 |
0.536 |
|
| 2007 |
Lanteri CA, Johnson JD, Waters NC. Recent advances in malaria drug discovery. Recent Patents On Anti-Infective Drug Discovery. 2: 95-114. PMID 18221166 DOI: 10.2174/157489107780832640 |
0.422 |
|
| 2006 |
Dow GS, Heady TN, Bhattacharjee AK, Caridha D, Gerena L, Gettayacamin M, Lanteri CA, Obaldia N, Roncal N, Shearer T, Smith PL, Tungtaeng A, Wolf L, Cabezas M, Yourick D, et al. Utility of alkylaminoquinolinyl methanols as new antimalarial drugs. Antimicrobial Agents and Chemotherapy. 50: 4132-43. PMID 16966402 DOI: 10.1128/Aac.00631-06 |
0.359 |
|
| 2006 |
Lanteri CA, Stewart ML, Brock JM, Alibu VP, Meshnick SR, Tidwell RR, Barrett MP. Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance. Molecular Pharmacology. 70: 1585-92. PMID 16912218 DOI: 10.1124/Mol.106.024653 |
0.562 |
|
| 2004 |
Lanteri CA, Trumpower BL, Tidwell RR, Meshnick SR. DB75, a novel trypanocidal agent, disrupts mitochondrial function in Saccharomyces cerevisiae. Antimicrobial Agents and Chemotherapy. 48: 3968-74. PMID 15388460 DOI: 10.1128/Aac.48.10.3968-3974.2004 |
0.537 |
|
| Show low-probability matches. |